Company Filing History:
Years Active: 2014
Title: Innovations of Jérôme Dorbais in Multiple Sclerosis Treatment.
Introduction
Jérôme Dorbais is an accomplished inventor based in Annecy, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for multiple sclerosis. His innovative work has led to the creation of valuable compounds that hold promise for patients suffering from this debilitating condition.
Latest Patents
Jérôme Dorbais holds a patent for "Oxadiazole fused heterocyclic derivatives useful for the treatment of multiple sclerosis." This invention provides compounds of Formula (I) that are designed to treat multiple sclerosis and other related diseases. His patent portfolio includes 1 patent that showcases his dedication to advancing medical science.
Career Highlights
Jérôme is currently employed at Merck Serono S.A., a leading biopharmaceutical company. His role at Merck Serono allows him to collaborate with other experts in the field and contribute to groundbreaking research and development efforts. His work is instrumental in pushing the boundaries of what is possible in the treatment of neurological disorders.
Collaborations
Throughout his career, Jérôme has worked alongside talented colleagues such as Mathilde Muzerelle and Anna Quattropani. These collaborations have fostered an environment of innovation and creativity, leading to the development of new therapeutic solutions.
Conclusion
Jérôme Dorbais exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to the treatment of multiple sclerosis through his patented inventions highlight the importance of research and collaboration in advancing healthcare solutions.